EP2707008A4 - Utilisation d'arsenic dans la protection contre une thérapie contre le cancer - Google Patents

Utilisation d'arsenic dans la protection contre une thérapie contre le cancer

Info

Publication number: EP2707008A4
Authority: EP; European Patent Office
Prior art keywords: arsenic; protection against; cancer therapy; against cancer; therapy
Prior art date: 2011-05-12
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP12781877.1A

Other languages

German (de)

English (en)

Other versions

EP2707008A1 (fr

Inventor

Zhi-Min Yuan

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University of Texas System

University of Texas at Austin

Original Assignee

University of Texas System

University of Texas at Austin

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-05-12

Filing date

2012-05-11

Publication date

2014-11-26

2011-05-18 Priority claimed from US13/110,737 external-priority patent/US8834938B2/en

2012-05-11 Application filed by University of Texas System, University of Texas at Austin filed Critical University of Texas System

2014-03-19 Publication of EP2707008A1 publication Critical patent/EP2707008A1/fr

2014-11-26 Publication of EP2707008A4 publication Critical patent/EP2707008A4/fr

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Toxicology (AREA)
Inorganic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

EP12781877.1A 2011-05-12 2012-05-11 Utilisation d'arsenic dans la protection contre une thérapie contre le cancer Withdrawn EP2707008A4 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201113106516A	2011-05-12	2011-05-12
US13/110,737 US8834938B2 (en)	2011-05-18	2011-05-18	Use of arsenic for cancer therapy protection
PCT/US2012/037560 WO2012155061A1 (fr)	2011-05-12	2012-05-11	Utilisation d'arsenic dans la protection contre une thérapie contre le cancer

Publications (2)

Publication Number	Publication Date
EP2707008A1 EP2707008A1 (fr)	2014-03-19
EP2707008A4 true EP2707008A4 (fr)	2014-11-26

Family

ID=47139696

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP12781877.1A Withdrawn EP2707008A4 (fr)	2011-05-12	2012-05-11	Utilisation d'arsenic dans la protection contre une thérapie contre le cancer

Country Status (5)

Country	Link
EP (1)	EP2707008A4 (fr)
JP (1)	JP2014513698A (fr)
CN (1)	CN103826645A (fr)
CA (1)	CA2835631A1 (fr)
WO (1)	WO2012155061A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN104546757A (zh) *	2014-12-25	2015-04-29	海南卫康制药(潜山)有限公司	一种白消安组合物冻干片及其制备方法
CN114028425A (zh) *	2021-09-24	2022-02-11	上海交通大学医学院附属新华医院	硫化砷及其与放疗联合在治疗横纹肌肉瘤上的应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20030058019A (ko) *	2001-12-29	2003-07-07	한국원자력연구소	삼산화비소(Ａｓ₂Ｏ₃)를 유효 성분으로 포함하는 방사선치료증진제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7405080B2 (en) *	2000-03-23	2008-07-29	Voellmy Richard W	Compositions and methods relating to prevention of chemotherapy-induced alopecia
US20090246291A1 (en) *	2008-03-27	2009-10-01	Angelika Burger	Method and compositions for treatment of cancer
US8795738B2 (en) *	2009-11-12	2014-08-05	Board Of Regents Of The University Of Texas System	Use of arsenic for cancer therapy protection

2012
- 2012-05-11 JP JP2014510500A patent/JP2014513698A/ja active Pending
- 2012-05-11 CA CA2835631A patent/CA2835631A1/fr not_active Abandoned
- 2012-05-11 CN CN201280034414.5A patent/CN103826645A/zh active Pending
- 2012-05-11 EP EP12781877.1A patent/EP2707008A4/fr not_active Withdrawn
- 2012-05-11 WO PCT/US2012/037560 patent/WO2012155061A1/fr not_active Ceased

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20030058019A (ko) *	2001-12-29	2003-07-07	한국원자력연구소	삼산화비소(Ａｓ₂Ｏ₃)를 유효 성분으로 포함하는 방사선치료증진제

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 200380, Derwent World Patents Index; AN 2003-861793, XP002730750 *
FARAH I O ET AL: "Differential protection and transactivation of P53, P21, Bcl2, PCNA, cyclin G, and MDM2 genes in rat liver and the HepG2 cell line upon exposure to pifithrin", BIOMEDICAL SCIENCES INSTRUMENTATION, INSTRUMENT SOCIETY OF AMERICA, PITTSBURGH, US, vol. 43, 1 January 2007 (2007-01-01), pages 116 - 121, XP009180503, ISSN: 0067-8856 *
KUMAR P ET AL: "Arsenic trioxide enhances the therapeutic efficacy of radiation treatment of oral squamous carcinoma while protecting bone", MOLECULAR CANCER THERAPEUTICS 2008 US, vol. 7, no. 7, 2008, pages 2060 - 2069, XP055134570, ISSN: 1535-7163 *
See also references of WO2012155061A1 *
SHEN S-X ET AL: "USE OF ARSENIC TRIOXIDE (AS2O3) IN THE TREATMENT OF ACUTE PROMYELOCITIC LEUKEMIA (APL): II. CLINICAL EFFICACY AND PHARMACOKINETICS IN RELAPSED PATIENTS", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 89, no. 9, 1 May 1997 (1997-05-01), pages 3354 - 3360, XP000891715, ISSN: 0006-4971 *

Also Published As

Publication number	Publication date
CA2835631A1 (fr)	2012-11-15
WO2012155061A1 (fr)	2012-11-15
EP2707008A1 (fr)	2014-03-19
JP2014513698A (ja)	2014-06-05
CN103826645A (zh)	2014-05-28

Similar Documents

Publication	Publication Date	Title
CY2019008I1 (el)	2019-11-27	Χρηση τροποποιημενων απο χιμαιρικο αντιγονικο υποδοχεα τ κυτταρων στη θεραπευτικη αγωγη καρκινου
LTPA2018013I1 (lt)	2018-11-12	Antivirusinė terapija
ZA201207574B (en)	2014-09-25	Phytocannabinoids in the treatment of cancer
EP2773637A4 (fr)	2015-03-11	Composés de benzènesulfonamide et leur utilisation en tant qu'agents thérapeutiques
EP2903510A4 (fr)	2016-08-10	Stimulation ventriculaire dans des applications cardiaques
HRP20181855T1 (hr)	2018-12-28	Lipidi za formulacije namijenjene unosu terapijskog sredstva
IL234989B (en)	2018-04-30	Compounds and compositions thereof for treating cancer
EP2819822A4 (fr)	2015-12-02	Compositions cationiques polymérisables et leurs procédés d'utilisation
PT3042910T (pt)	2019-04-16	2'-espiro-nucleósidos para utilização na terapia da hepatite c
PL2681227T3 (pl)	2016-08-31	Amidofosforanowe pochodne 5-fluoro-2'-deoksyurydyny do zastosowania w leczeniu raka
GB201115711D0 (en)	2011-10-26	Phyto-cannabinoids for use in the treatment of cancer
HUE042535T2 (hu)	2019-07-29	Szerves vegyület a májrák kezelésére
ZA201403372B (en)	2017-08-30	Therapeutic agents and uses thereof
FR2989710B1 (fr)	2015-09-18	Protection contre le soleil
EP2867209A4 (fr)	2015-11-25	Composés et leurs utilisations thérapeutiques
EP2804606A4 (fr)	2015-04-08	Préparations thérapeutiques topiques
EP3049536A4 (fr)	2017-08-02	Procédés et compositions concernant une thérapie anticancéreuse au moyen d'agents endommageant l'adn
EP2925332A4 (fr)	2016-12-21	Thérapie de vaccination placentaire contre le cancer
IL238453A0 (en)	2015-06-30	Trans-clomiphene for use in cancer treatment
EP2702177A4 (fr)	2014-11-12	Signatures génomiques d'une métastase dans le cancer de la prostate
GB2515440B (en)	2017-02-08	Vesicular Formulations for use in the treatment of Rosacea
EP2726869A4 (fr)	2015-03-11	Mutations somatiques de l'atrx dans le cancer du cerveau
SI2872176T1 (sl)	2017-08-31	Karboranilporfirin za uporabo pri zdravljenju raka
EP2909285A4 (fr)	2016-06-15	Agents gélifiants et leurs procédés d'utilisation
EP2707008A4 (fr)	2014-11-26	Utilisation d'arsenic dans la protection contre une thérapie contre le cancer

Legal Events

Date	Code	Title	Description
2014-02-14	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2014-03-19	17P	Request for examination filed	Effective date: 20131205
2014-03-19	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2014-08-20	DAX	Request for extension of the european patent (deleted)
2014-11-26	A4	Supplementary search report drawn up and despatched	Effective date: 20141024
2014-11-26	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 33/36 20060101AFI20141017BHEP Ipc: A61P 43/00 20060101ALI20141017BHEP Ipc: A61P 39/00 20060101ALI20141017BHEP
2015-11-13	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2015-12-16	18D	Application deemed to be withdrawn	Effective date: 20150522